Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Miriam, Lenhard"'
Objective The “cystosarcoma phyllodes” of the breast is a rare entity which accounts for 0.5% of all breast neoplasms. The aim of our study was to analyse the clinical management with respect to patient outcome. Study design The data of 5270 pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54060f0e7072b3ce8f79dc3a788a9706
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/84518
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/84518
Autor:
Michael Untch, Sandra Rueckert, Miriam Lenhard, Thorsten R. C. Johnson, Isabelle Himsl, Nina Ditsch, Klaus Friese
Objective To assess the number and quality of scientific articles published by authors from the European Union (EU) and Germany in the field of obstetrics and gynecology. Study design Scientific articles published during the years 1980–2003 covered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104449dcafedf9c83f260649fdf0ac39
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/84521
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/84521
Autor:
Sabine Heublein, Doris Mayr, Thomas Vrekoussis, Klaus Friese, Simone S Hofmann, Udo Jeschke, Miriam Lenhard
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e71791 (2013)
Follicle stimulating hormone receptor (FSHR) and luteinizing hormone receptor (LHCGR) were demonstrated to impact upon survival of patients suffering from epithelial ovarian cancer (EOC). Though structure wise the G-protein coupled estrogen receptor
Externí odkaz:
https://doaj.org/article/64f9e464967a4d50b3434abf7f478016
Autor:
Norman Häfner, Ingo B. Runnebaum, Thomas Dimpfl, Christoph Altgassen, Peter Hillemanns, Miriam Lenhard, K. Ulrich Petry, Alba Fishta, Ute Mahnert, Matthias Dürst, Achim Schneider, Mieczyslaw Gajda, Christiane Greinke, Heike Hoyer
Publikováno v:
Oncotarget
ResearcherID
ResearcherID
// Matthias Durst 1 , Heike Hoyer 2 , Christoph Altgassen 3 , Christiane Greinke 1 , Norman Hafner 1 , Alba Fishta 1 , Mieczyslaw Gajda 4 , Ute Mahnert 5 , Peter Hillemanns 6 , Thomas Dimpfl 7 , Miriam Lenhard 8 , K. Ulrich Petry 9 , Ingo B. Runnebau
Autor:
Klaus Friese, Sabine Heublein, Udo Jeschke, Artur Mayerhofer, Maria Cristina Jarrin-Franco, Doris Mayr, Miriam Lenhard
Publikováno v:
International Journal of Molecular Sciences, Vol 15, Iss 9, Pp 15161-15172 (2014)
International Journal of Molecular Sciences; Volume 15; Issue 9; Pages: 15161-15172
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 15; Issue 9; Pages: 15161-15172
International Journal of Molecular Sciences
Ovarian granulosa cell tumors (GCTs) are thought to arise from cells of the ovarian follicle and comprise a rare entity of ovarian masses. We recently identified the G-protein-coupled estrogen receptor (GPER/GPR30) to be present in granulosa cells, t
Publikováno v:
MMW - Fortschritte der Medizin. 154:61-64
Publikováno v:
MMW - Fortschritte der Medizin. 154:64-69
Autor:
Miriam Lenhard, Petra Stieber, Dorothea Nagel, Linda Hertlein, Karin Hofmann, Alexander Burges, Katja Krocker, A. Kirschenhofer, Doris Mayr, Sophie Fürst
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 50:2181-2188
Background: Human epididymis protein 4 (HE4) is described as a useful new biomarker in ovarian cancer. As HE4 is neither tumor nor organ specific, we intensively investigated the occurrence of this protein in female and male patients with various ben
Autor:
Julia Gallwas, Carolin Strauss, Nina Ditsch, Doris Stoeckl, Doris Mayr, Tobias Weissenbacher, Miriam Lenhard, Andrea Vodermaier, Udo Jeschke, Monika Graeser, Klaus Friese
Publikováno v:
Oncology Letters. 4:665-671
Non-steroidal nuclear receptors play a major role in breast cancer development. A correlation among, and possible prognostic function of, the members of the nuclear receptor superfamily has been discussed controversially over the years. Hence, we con
Autor:
Sileny Han, Manfred Kaufmann, Brigitte Rack, Alistair Ring, Nadia Harbeck, Tanja Fehm, Sabine C. Linn, J Giermek, Michael J. Halaska, M. Bontenbal, Volkmar Müller, Valentina Nekljudova, Mina Mhallem Gziri, Kristel Van Calsteren, Liesbeth Heyns, Sibylle Loibl, Gunter von Minckwitz, Frédéric Amant, Ben Van Calster, Miriam Lenhard, Pieter J. Westenend, B. Schlehe
Publikováno v:
lancet oncology, 13(9), 887-896. Lancet Publishing Group
Lancet Oncology, 13(9), 887-896. Lancet Publishing Group
Lancet Oncology, 13(9), 887-896. Lancet Publishing Group
Summary Background Little is known about the treatment of breast cancer during pregnancy. We aimed to determine whether treatment for breast cancer during pregnancy is safe for both mother and child. Methods We recruited patients from seven European